| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Peroxide | 26 | 2024 | 730 | 6.910 |
Why?
|
| Nitric Oxide Synthase Type III | 49 | 2024 | 705 | 5.650 |
Why?
|
| Nitric Oxide Synthase | 68 | 2019 | 908 | 5.050 |
Why?
|
| Endothelium, Vascular | 66 | 2022 | 4433 | 3.750 |
Why?
|
| Nitric Oxide | 41 | 2024 | 2135 | 3.270 |
Why?
|
| Oxidative Stress | 17 | 2024 | 3115 | 2.470 |
Why?
|
| rac1 GTP-Binding Protein | 8 | 2024 | 242 | 2.370 |
Why?
|
| Endothelial Cells | 20 | 2022 | 3550 | 2.200 |
Why?
|
| Lysophospholipids | 12 | 2013 | 337 | 2.010 |
Why?
|
| Caveolins | 14 | 2010 | 102 | 2.000 |
Why?
|
| Sphingosine | 11 | 2013 | 307 | 1.870 |
Why?
|
| Myocytes, Cardiac | 9 | 2022 | 1667 | 1.850 |
Why?
|
| Signal Transduction | 45 | 2024 | 23415 | 1.710 |
Why?
|
| Cattle | 46 | 2014 | 3841 | 1.690 |
Why?
|
| Oxidation-Reduction | 13 | 2024 | 2231 | 1.590 |
Why?
|
| Amino Acid Oxidoreductases | 19 | 1995 | 149 | 1.490 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2022 | 831 | 1.400 |
Why?
|
| Enzyme Activation | 28 | 2019 | 3591 | 1.380 |
Why?
|
| AMP-Activated Protein Kinases | 7 | 2020 | 597 | 1.170 |
Why?
|
| Phosphorylation | 38 | 2024 | 8311 | 1.150 |
Why?
|
| Adenosine Diphosphate | 4 | 2014 | 422 | 1.130 |
Why?
|
| Nitroglycerin | 3 | 2015 | 329 | 1.020 |
Why?
|
| Reactive Oxygen Species | 7 | 2024 | 2137 | 0.910 |
Why?
|
| Aorta | 16 | 2015 | 2041 | 0.850 |
Why?
|
| Caveolin 1 | 13 | 2014 | 255 | 0.850 |
Why?
|
| Calmodulin | 8 | 2010 | 218 | 0.850 |
Why?
|
| Friedreich Ataxia | 1 | 2023 | 77 | 0.820 |
Why?
|
| Vasodilator Agents | 3 | 2015 | 973 | 0.790 |
Why?
|
| Membrane Proteins | 18 | 2016 | 7847 | 0.780 |
Why?
|
| Simvastatin | 3 | 2022 | 346 | 0.770 |
Why?
|
| Cells, Cultured | 51 | 2021 | 18937 | 0.760 |
Why?
|
| Animals | 124 | 2024 | 168202 | 0.730 |
Why?
|
| RNA, Small Interfering | 13 | 2014 | 3419 | 0.730 |
Why?
|
| Heart Failure | 5 | 2024 | 11670 | 0.720 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2023 | 2872 | 0.710 |
Why?
|
| Caveolae | 3 | 2012 | 54 | 0.680 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2012 | 1169 | 0.680 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2019 | 26 | 0.670 |
Why?
|
| Molecular Imaging | 2 | 2019 | 814 | 0.670 |
Why?
|
| Oxidants | 4 | 2021 | 169 | 0.660 |
Why?
|
| Receptors, Cell Surface | 9 | 2005 | 2802 | 0.650 |
Why?
|
| Biosensing Techniques | 4 | 2019 | 647 | 0.620 |
Why?
|
| Amino Acids | 5 | 2024 | 1718 | 0.580 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 431 | 0.540 |
Why?
|
| Receptors, Bradykinin | 3 | 2001 | 19 | 0.530 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2011 | 174 | 0.530 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 18220 | 0.510 |
Why?
|
| Protease Inhibitors | 1 | 2019 | 753 | 0.510 |
Why?
|
| Insulin | 7 | 2017 | 6593 | 0.510 |
Why?
|
| Immunoblotting | 10 | 2014 | 1646 | 0.500 |
Why?
|
| Vasoconstriction | 2 | 2009 | 592 | 0.490 |
Why?
|
| Myocardial Contraction | 9 | 2011 | 1515 | 0.490 |
Why?
|
| Transfection | 21 | 2009 | 5765 | 0.490 |
Why?
|
| Fungal Proteins | 1 | 2019 | 907 | 0.490 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2016 | 124 | 0.490 |
Why?
|
| Immediate-Early Proteins | 3 | 2003 | 444 | 0.480 |
Why?
|
| Cardiomegaly | 3 | 2023 | 590 | 0.470 |
Why?
|
| Protein Processing, Post-Translational | 10 | 2016 | 1971 | 0.470 |
Why?
|
| Myocardium | 13 | 2012 | 4725 | 0.470 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2014 | 40 | 0.460 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2003 | 1250 | 0.460 |
Why?
|
| Arginine | 6 | 2013 | 933 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2017 | 2456 | 0.450 |
Why?
|
| Homoarginine | 1 | 2013 | 9 | 0.450 |
Why?
|
| Amidinotransferases | 1 | 2013 | 11 | 0.450 |
Why?
|
| Cell Movement | 9 | 2024 | 5201 | 0.450 |
Why?
|
| Bradykinin | 5 | 2001 | 208 | 0.450 |
Why?
|
| Calcium | 9 | 2019 | 5717 | 0.450 |
Why?
|
| Palmitic Acid | 6 | 2002 | 149 | 0.440 |
Why?
|
| Tetrazoles | 1 | 2019 | 909 | 0.430 |
Why?
|
| Angiotensin II | 3 | 2015 | 849 | 0.430 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3245 | 0.430 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 2 | 2009 | 30 | 0.420 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 673 | 0.390 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2012 | 162 | 0.390 |
Why?
|
| Lymphokines | 3 | 2003 | 925 | 0.380 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2009 | 2863 | 0.370 |
Why?
|
| Gene Knockdown Techniques | 4 | 2024 | 1608 | 0.370 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2007 | 517 | 0.350 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2014 | 495 | 0.350 |
Why?
|
| Mice | 35 | 2024 | 81368 | 0.340 |
Why?
|
| Epinephrine | 9 | 2007 | 792 | 0.330 |
Why?
|
| COS Cells | 10 | 2003 | 1130 | 0.330 |
Why?
|
| Vascular Endothelial Growth Factor A | 10 | 2022 | 3492 | 0.330 |
Why?
|
| Sulfhydryl Compounds | 2 | 2009 | 301 | 0.320 |
Why?
|
| GTP Cyclohydrolase | 1 | 2009 | 47 | 0.320 |
Why?
|
| Nucleotides, Cyclic | 1 | 2009 | 84 | 0.320 |
Why?
|
| Capillary Permeability | 1 | 2012 | 773 | 0.320 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2005 | 1692 | 0.310 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2009 | 132 | 0.310 |
Why?
|
| Acylation | 8 | 2010 | 96 | 0.310 |
Why?
|
| Myristic Acids | 7 | 1998 | 49 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1242 | 0.300 |
Why?
|
| Cell Compartmentation | 6 | 1998 | 384 | 0.300 |
Why?
|
| Thiolester Hydrolases | 3 | 2013 | 90 | 0.300 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2007 | 62 | 0.290 |
Why?
|
| Enzyme Inhibitors | 8 | 2009 | 3705 | 0.290 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1113 | 0.290 |
Why?
|
| Microfilament Proteins | 2 | 2009 | 1130 | 0.280 |
Why?
|
| Recombinant Proteins | 12 | 2006 | 6520 | 0.280 |
Why?
|
| Metabolome | 1 | 2014 | 988 | 0.280 |
Why?
|
| Neuropeptides | 1 | 2012 | 944 | 0.270 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2016 | 1492 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 2 | 2009 | 1602 | 0.270 |
Why?
|
| Vasodilation | 3 | 2015 | 962 | 0.270 |
Why?
|
| Muscle Tonus | 2 | 2003 | 82 | 0.260 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2006 | 94 | 0.260 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2005 | 546 | 0.260 |
Why?
|
| Phosphoproteins | 3 | 2009 | 2445 | 0.260 |
Why?
|
| Autophagy | 1 | 2014 | 1327 | 0.260 |
Why?
|
| Down-Regulation | 4 | 2020 | 2916 | 0.250 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 433 | 0.250 |
Why?
|
| Dependovirus | 2 | 2022 | 712 | 0.250 |
Why?
|
| Cyclic GMP | 7 | 2009 | 395 | 0.250 |
Why?
|
| Rats, Wistar | 2 | 2019 | 1848 | 0.240 |
Why?
|
| Protein Isoforms | 3 | 2022 | 1697 | 0.240 |
Why?
|
| Myristic Acid | 7 | 2002 | 49 | 0.240 |
Why?
|
| Mice, Knockout | 13 | 2016 | 14388 | 0.240 |
Why?
|
| Nitrogen | 1 | 2005 | 345 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2011 | 10754 | 0.230 |
Why?
|
| Palmitic Acids | 4 | 1998 | 53 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta | 7 | 2009 | 242 | 0.230 |
Why?
|
| Isoenzymes | 7 | 2006 | 1687 | 0.220 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 666 | 0.220 |
Why?
|
| Calcium Signaling | 2 | 2007 | 734 | 0.220 |
Why?
|
| Receptors, Adrenergic | 8 | 1992 | 155 | 0.210 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 115 | 0.210 |
Why?
|
| Receptors, Growth Factor | 2 | 2003 | 326 | 0.210 |
Why?
|
| Catalase | 2 | 2014 | 218 | 0.210 |
Why?
|
| Molecular Sequence Data | 19 | 2016 | 17630 | 0.210 |
Why?
|
| Cyclosporine | 2 | 2002 | 776 | 0.200 |
Why?
|
| Androstadienes | 4 | 2007 | 348 | 0.200 |
Why?
|
| Adrenergic beta-Agonists | 5 | 2011 | 346 | 0.200 |
Why?
|
| Heart Ventricles | 6 | 2013 | 3796 | 0.200 |
Why?
|
| Endothelium | 3 | 2008 | 764 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 558 | 0.200 |
Why?
|
| Animals, Newborn | 3 | 2024 | 2669 | 0.200 |
Why?
|
| Glutathione | 3 | 2019 | 582 | 0.200 |
Why?
|
| Cell Line | 14 | 2014 | 15577 | 0.200 |
Why?
|
| Rats | 20 | 2022 | 23716 | 0.190 |
Why?
|
| Receptors, Adrenergic, alpha | 7 | 1984 | 146 | 0.190 |
Why?
|
| Base Sequence | 14 | 2005 | 12420 | 0.190 |
Why?
|
| Heart | 4 | 2010 | 4403 | 0.190 |
Why?
|
| Serine | 5 | 2009 | 830 | 0.190 |
Why?
|
| Cytosol | 3 | 2019 | 886 | 0.190 |
Why?
|
| Physical Therapy Modalities | 3 | 1995 | 530 | 0.190 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 328 | 0.180 |
Why?
|
| Biological Phenomena | 1 | 2021 | 28 | 0.180 |
Why?
|
| Histamine | 1 | 2022 | 499 | 0.180 |
Why?
|
| Ataxia | 1 | 2023 | 306 | 0.180 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 2409 | 0.180 |
Why?
|
| Isoproterenol | 6 | 2011 | 397 | 0.180 |
Why?
|
| Humans | 71 | 2024 | 760740 | 0.180 |
Why?
|
| Cloning, Molecular | 7 | 1998 | 4172 | 0.180 |
Why?
|
| Alanine | 2 | 2022 | 609 | 0.180 |
Why?
|
| Angina Pectoris | 2 | 2015 | 959 | 0.170 |
Why?
|
| Receptors, Lysosphingolipid | 3 | 2013 | 122 | 0.170 |
Why?
|
| Palmitoyl-CoA Hydrolase | 1 | 1999 | 17 | 0.170 |
Why?
|
| Spodoptera | 4 | 2006 | 141 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2018 | 3730 | 0.170 |
Why?
|
| Kinetics | 12 | 2009 | 6370 | 0.170 |
Why?
|
| Cyclic AMP | 5 | 2011 | 1463 | 0.170 |
Why?
|
| Amino Acid Sequence | 15 | 2016 | 13442 | 0.160 |
Why?
|
| Precipitin Tests | 4 | 2002 | 813 | 0.160 |
Why?
|
| Anaphylaxis | 1 | 2006 | 757 | 0.160 |
Why?
|
| Carbachol | 4 | 1998 | 223 | 0.160 |
Why?
|
| Heart Rate | 4 | 2009 | 4181 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 2639 | 0.160 |
Why?
|
| Hypoglycemic Agents | 2 | 2010 | 3085 | 0.160 |
Why?
|
| Ceramides | 1 | 1999 | 200 | 0.150 |
Why?
|
| Stereotyping | 1 | 2000 | 239 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2011 | 485 | 0.150 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 363 | 0.150 |
Why?
|
| Sirtuins | 1 | 2021 | 319 | 0.150 |
Why?
|
| Receptors, Lysophospholipid | 3 | 2003 | 40 | 0.150 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 229 | 0.150 |
Why?
|
| DNA, Complementary | 4 | 2005 | 1989 | 0.150 |
Why?
|
| Protein Binding | 8 | 2007 | 9345 | 0.150 |
Why?
|
| Blood Platelets | 9 | 2016 | 2478 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2019 | 5672 | 0.150 |
Why?
|
| Occupations | 1 | 2000 | 516 | 0.150 |
Why?
|
| Sequence Deletion | 3 | 1998 | 1490 | 0.140 |
Why?
|
| Fluorescent Dyes | 4 | 2013 | 1901 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2017 | 2057 | 0.140 |
Why?
|
| Genetic Vectors | 3 | 2019 | 3392 | 0.140 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 1376 | 0.140 |
Why?
|
| Muscle Relaxation | 2 | 2010 | 138 | 0.140 |
Why?
|
| HEK293 Cells | 4 | 2015 | 4269 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 748 | 0.140 |
Why?
|
| Diabetic Angiopathies | 1 | 2001 | 803 | 0.130 |
Why?
|
| Neprilysin | 1 | 2019 | 478 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1650 | 0.130 |
Why?
|
| Alexander Disease | 1 | 2015 | 15 | 0.130 |
Why?
|
| GTP-Binding Proteins | 6 | 1999 | 949 | 0.130 |
Why?
|
| Proteins | 2 | 2009 | 6030 | 0.130 |
Why?
|
| Teaching Rounds | 1 | 2020 | 276 | 0.130 |
Why?
|
| Mice, Transgenic | 5 | 2023 | 9526 | 0.130 |
Why?
|
| Microscopy, Confocal | 3 | 2015 | 1970 | 0.130 |
Why?
|
| Renin-Angiotensin System | 1 | 2020 | 737 | 0.120 |
Why?
|
| Actin-Related Protein 2-3 Complex | 2 | 2016 | 61 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 5838 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 5780 | 0.120 |
Why?
|
| Baculoviridae | 1 | 1995 | 115 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2015 | 206 | 0.120 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2015 | 94 | 0.120 |
Why?
|
| RNA, Transfer, Amino Acyl | 1 | 2014 | 46 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 161 | 0.120 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 1007 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 304 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2001 | 4512 | 0.120 |
Why?
|
| Troponin T | 1 | 2019 | 780 | 0.120 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2014 | 41 | 0.120 |
Why?
|
| Thrombopoiesis | 1 | 2016 | 164 | 0.110 |
Why?
|
| Plasmids | 3 | 2005 | 2265 | 0.110 |
Why?
|
| Cell Membrane | 10 | 2000 | 3680 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 550 | 0.110 |
Why?
|
| Energy Metabolism | 2 | 2019 | 2878 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1994 | 310 | 0.110 |
Why?
|
| Biological Transport | 6 | 1999 | 2089 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2005 | 472 | 0.110 |
Why?
|
| Interleukin-1 | 3 | 2004 | 1248 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2021 | 1099 | 0.110 |
Why?
|
| DNA Primers | 5 | 2004 | 2817 | 0.110 |
Why?
|
| Autonomic Nervous System | 1 | 1998 | 704 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 476 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 1040 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 12143 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1517 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2019 | 2048 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 3 | 2013 | 1349 | 0.110 |
Why?
|
| Multigene Family | 2 | 1997 | 1076 | 0.110 |
Why?
|
| Transcription, Genetic | 5 | 2018 | 7583 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2014 | 420 | 0.110 |
Why?
|
| Pyloric Stenosis | 1 | 1992 | 28 | 0.110 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 258 | 0.100 |
Why?
|
| Homeostasis | 4 | 2021 | 3321 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2015 | 718 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2009 | 1241 | 0.100 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2013 | 90 | 0.100 |
Why?
|
| Fatty Acids | 3 | 2008 | 1808 | 0.100 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 201 | 0.100 |
Why?
|
| Methionine | 1 | 2015 | 572 | 0.100 |
Why?
|
| Methylene Blue | 1 | 1993 | 155 | 0.100 |
Why?
|
| Receptors, Muscarinic | 3 | 1998 | 157 | 0.100 |
Why?
|
| Nifedipine | 1 | 2012 | 221 | 0.100 |
Why?
|
| Actins | 2 | 2013 | 2051 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1993 | 241 | 0.100 |
Why?
|
| Stroke | 2 | 2013 | 9715 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2012 | 140 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1265 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 699 | 0.100 |
Why?
|
| Subcellular Fractions | 3 | 2004 | 531 | 0.100 |
Why?
|
| Enzyme Stability | 1 | 2011 | 219 | 0.100 |
Why?
|
| Megakaryocytes | 1 | 2016 | 566 | 0.090 |
Why?
|
| Hypertension | 3 | 2020 | 8532 | 0.090 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2011 | 102 | 0.090 |
Why?
|
| Methyltransferases | 1 | 2014 | 373 | 0.090 |
Why?
|
| Antioxidants | 1 | 2019 | 1669 | 0.090 |
Why?
|
| Time Factors | 7 | 2010 | 39908 | 0.090 |
Why?
|
| Lipase | 1 | 2013 | 324 | 0.090 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 242 | 0.090 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2010 | 87 | 0.090 |
Why?
|
| Guanylate Cyclase | 3 | 2009 | 205 | 0.090 |
Why?
|
| RNA, Messenger | 6 | 2005 | 12759 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2010 | 4117 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2016 | 1112 | 0.090 |
Why?
|
| Nitrosation | 2 | 2007 | 25 | 0.090 |
Why?
|
| Proteomics | 1 | 2024 | 3836 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 834 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 682 | 0.090 |
Why?
|
| Glutathione Reductase | 1 | 2009 | 25 | 0.090 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2000 | 24 | 0.090 |
Why?
|
| Saphenous Vein | 3 | 2003 | 516 | 0.090 |
Why?
|
| Phosphorus Radioisotopes | 2 | 2002 | 100 | 0.090 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2009 | 25 | 0.090 |
Why?
|
| Casein Kinase II | 2 | 2016 | 122 | 0.090 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2009 | 32 | 0.090 |
Why?
|
| Naphthalimides | 1 | 2009 | 22 | 0.090 |
Why?
|
| Interferon-gamma | 3 | 1995 | 3145 | 0.090 |
Why?
|
| Genes | 1 | 1994 | 1823 | 0.090 |
Why?
|
| Lentivirus | 1 | 2013 | 507 | 0.080 |
Why?
|
| Thionucleotides | 1 | 2009 | 107 | 0.080 |
Why?
|
| Consensus Sequence | 3 | 1996 | 364 | 0.080 |
Why?
|
| Electrochemistry | 1 | 2009 | 145 | 0.080 |
Why?
|
| Enzyme Activators | 1 | 2009 | 57 | 0.080 |
Why?
|
| Electric Impedance | 1 | 2014 | 751 | 0.080 |
Why?
|
| Cell Size | 1 | 2011 | 624 | 0.080 |
Why?
|
| Streptokinase | 1 | 1989 | 186 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 2467 | 0.080 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1992 | 306 | 0.080 |
Why?
|
| Heart Failure, Diastolic | 1 | 2010 | 76 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 694 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 1739 | 0.080 |
Why?
|
| Terpenes | 1 | 2009 | 96 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 15498 | 0.080 |
Why?
|
| Copper | 1 | 2011 | 367 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 174 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 675 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2015 | 2764 | 0.080 |
Why?
|
| Aldehyde-Lyases | 1 | 2008 | 13 | 0.080 |
Why?
|
| Phenylhydrazines | 1 | 2008 | 28 | 0.080 |
Why?
|
| Liver | 5 | 2016 | 7512 | 0.080 |
Why?
|
| Blotting, Northern | 3 | 2003 | 1545 | 0.080 |
Why?
|
| Guanylyl Imidodiphosphate | 5 | 1984 | 37 | 0.080 |
Why?
|
| Adrenergic beta-3 Receptor Antagonists | 1 | 2007 | 1 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 7 | 2004 | 6074 | 0.080 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 213 | 0.070 |
Why?
|
| Pertussis Toxin | 3 | 2005 | 176 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1159 | 0.070 |
Why?
|
| Astrocytes | 1 | 2015 | 1341 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 654 | 0.070 |
Why?
|
| Models, Biological | 5 | 2013 | 9461 | 0.070 |
Why?
|
| Leukopenia | 1 | 2008 | 213 | 0.070 |
Why?
|
| Disulfides | 1 | 2009 | 464 | 0.070 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 144 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2012 | 1170 | 0.070 |
Why?
|
| Half-Life | 1 | 2008 | 650 | 0.070 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2010 | 424 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2015 | 8473 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2007 | 350 | 0.070 |
Why?
|
| Students, Medical | 1 | 2020 | 1936 | 0.070 |
Why?
|
| Lipoproteins, LDL | 1 | 2010 | 642 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 1182 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3873 | 0.070 |
Why?
|
| Coronary Disease | 2 | 2010 | 5911 | 0.070 |
Why?
|
| Protein Kinases | 2 | 2005 | 1606 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 615 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 412 | 0.070 |
Why?
|
| Phosphates | 2 | 2002 | 769 | 0.070 |
Why?
|
| Embolism | 1 | 1989 | 399 | 0.070 |
Why?
|
| Apoptosis | 2 | 2019 | 9476 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 489 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 484 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 1674 | 0.060 |
Why?
|
| Male | 22 | 2019 | 360402 | 0.060 |
Why?
|
| Cardiology | 1 | 2016 | 1656 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 858 | 0.060 |
Why?
|
| Virus Replication | 1 | 2013 | 2427 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 12966 | 0.060 |
Why?
|
| DNA | 6 | 1993 | 7196 | 0.060 |
Why?
|
| Biomedical Research | 2 | 2020 | 3426 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 22117 | 0.060 |
Why?
|
| Acetylation | 1 | 2007 | 1055 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2009 | 858 | 0.060 |
Why?
|
| Yohimbine | 3 | 1992 | 62 | 0.060 |
Why?
|
| Arteries | 1 | 2009 | 1120 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 506 | 0.060 |
Why?
|
| Prostaglandins E | 2 | 1982 | 166 | 0.060 |
Why?
|
| Cardiolipins | 1 | 2023 | 81 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2024 | 26183 | 0.060 |
Why?
|
| Guanosine Triphosphate | 3 | 1982 | 316 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 1983 | 157 | 0.050 |
Why?
|
| Phosphopeptides | 2 | 1996 | 240 | 0.050 |
Why?
|
| Marine Toxins | 1 | 2002 | 24 | 0.050 |
Why?
|
| Okadaic Acid | 1 | 2002 | 67 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 206 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2015 | 5034 | 0.050 |
Why?
|
| Calcium Channels | 2 | 1998 | 620 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2003 | 119 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 1141 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 1966 | 0.050 |
Why?
|
| Organ Preservation Solutions | 1 | 2003 | 100 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 1748 | 0.050 |
Why?
|
| CHO Cells | 2 | 1996 | 1387 | 0.050 |
Why?
|
| Models, Animal | 1 | 2009 | 2108 | 0.050 |
Why?
|
| Cricetinae | 3 | 1996 | 2424 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Caveolin 3 | 2 | 1998 | 24 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Tritium | 3 | 1996 | 706 | 0.050 |
Why?
|
| Catalysis | 1 | 2004 | 773 | 0.050 |
Why?
|
| Threonine | 1 | 2002 | 271 | 0.050 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2002 | 77 | 0.050 |
Why?
|
| Mitochondria | 2 | 2014 | 3619 | 0.050 |
Why?
|
| Albumins | 1 | 2004 | 575 | 0.050 |
Why?
|
| Mutagenesis | 2 | 1995 | 1230 | 0.050 |
Why?
|
| Oxazoles | 1 | 2002 | 199 | 0.050 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2003 | 267 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2016 | 4937 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 1997 | 3074 | 0.050 |
Why?
|
| Guanine Nucleotides | 1 | 1980 | 55 | 0.050 |
Why?
|
| Luminescence | 1 | 2001 | 108 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2004 | 517 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2011 | 2008 | 0.050 |
Why?
|
| Cystatins | 1 | 2000 | 55 | 0.050 |
Why?
|
| Protein Phosphatase 2 | 1 | 2002 | 231 | 0.050 |
Why?
|
| Regeneration | 1 | 2010 | 1505 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2008 | 1995 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 299 | 0.050 |
Why?
|
| Muscarinic Agonists | 2 | 1998 | 91 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 836 | 0.040 |
Why?
|
| Citrulline | 3 | 1995 | 107 | 0.040 |
Why?
|
| Sequence Alignment | 3 | 1998 | 2178 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 1894 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 1896 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2000 | 205 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1182 | 0.040 |
Why?
|
| Superoxides | 1 | 2001 | 387 | 0.040 |
Why?
|
| Capillaries | 1 | 2003 | 756 | 0.040 |
Why?
|
| Nitrates | 1 | 2001 | 263 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5878 | 0.040 |
Why?
|
| Naphthalenes | 1 | 2000 | 198 | 0.040 |
Why?
|
| Pain | 1 | 1995 | 5062 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2896 | 0.040 |
Why?
|
| Epitopes | 2 | 1996 | 2501 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2011 | 3027 | 0.040 |
Why?
|
| Depression, Chemical | 1 | 1998 | 184 | 0.040 |
Why?
|
| Neurons | 2 | 2015 | 9436 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 480 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 1998 | 75 | 0.040 |
Why?
|
| Glycosylation | 1 | 2001 | 1098 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2023 | 526 | 0.040 |
Why?
|
| Anemia | 1 | 2008 | 1504 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2019 | 197 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1996 | 283 | 0.040 |
Why?
|
| Enzyme Induction | 2 | 1996 | 452 | 0.040 |
Why?
|
| Calcimycin | 1 | 1998 | 213 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 427 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2016 | 2100 | 0.040 |
Why?
|
| Thioredoxins | 1 | 2019 | 202 | 0.040 |
Why?
|
| Flavonoids | 1 | 2000 | 445 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2003 | 8165 | 0.030 |
Why?
|
| Palmitates | 1 | 1997 | 70 | 0.030 |
Why?
|
| RNA Interference | 1 | 2005 | 2829 | 0.030 |
Why?
|
| Immunosorbent Techniques | 1 | 1996 | 174 | 0.030 |
Why?
|
| Cysteine | 2 | 2005 | 891 | 0.030 |
Why?
|
| Peptides | 2 | 2003 | 4354 | 0.030 |
Why?
|
| omega-N-Methylarginine | 2 | 1993 | 108 | 0.030 |
Why?
|
| Dystrophin | 1 | 1997 | 281 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1996 | 71 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 2016 | 1066 | 0.030 |
Why?
|
| Sheep | 2 | 1996 | 1436 | 0.030 |
Why?
|
| Actin-Related Protein 3 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 1997 | 427 | 0.030 |
Why?
|
| Hybrid Cells | 2 | 1994 | 422 | 0.030 |
Why?
|
| Sequence Tagged Sites | 1 | 1995 | 96 | 0.030 |
Why?
|
| Casein Kinase I | 1 | 2016 | 46 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 317 | 0.030 |
Why?
|
| Organisms, Genetically Modified | 1 | 2015 | 63 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2021 | 792 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2016 | 85 | 0.030 |
Why?
|
| Mutation | 4 | 2007 | 30015 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1996 | 1790 | 0.030 |
Why?
|
| Methods | 1 | 1996 | 1065 | 0.030 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1996 | 339 | 0.030 |
Why?
|
| Sodium | 1 | 1980 | 1588 | 0.030 |
Why?
|
| Sodium Hypochlorite | 1 | 2015 | 31 | 0.030 |
Why?
|
| Research Personnel | 1 | 2020 | 588 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 851 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10429 | 0.030 |
Why?
|
| Triethylenemelamine | 1 | 1974 | 1 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2000 | 1443 | 0.030 |
Why?
|
| Brain | 4 | 2006 | 27100 | 0.030 |
Why?
|
| RNA, Transfer, Ser | 1 | 2014 | 7 | 0.030 |
Why?
|
| Aging | 2 | 2010 | 8700 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 613 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 3606 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2004 | 2851 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1998 | 927 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 250 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12116 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2015 | 613 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1738 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 1995 | 4340 | 0.030 |
Why?
|
| Stomach | 1 | 1998 | 696 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3030 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2016 | 5109 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 1433 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1995 | 429 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 3088 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1996 | 537 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2016 | 860 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2020 | 1051 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1994 | 4611 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2014 | 218 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.030 |
Why?
|
| Radioligand Assay | 3 | 1997 | 366 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9586 | 0.030 |
Why?
|
| Endothelins | 1 | 1992 | 127 | 0.030 |
Why?
|
| Fluorescence | 1 | 2015 | 756 | 0.030 |
Why?
|
| Selenoproteins | 1 | 2014 | 215 | 0.030 |
Why?
|
| Rodentia | 1 | 1994 | 261 | 0.030 |
Why?
|
| Cholesterol | 2 | 2013 | 2902 | 0.030 |
Why?
|
| Intestine, Small | 1 | 1998 | 1207 | 0.020 |
Why?
|
| Adult | 4 | 2024 | 220995 | 0.020 |
Why?
|
| Binding, Competitive | 5 | 1992 | 1141 | 0.020 |
Why?
|
| Research Design | 1 | 2008 | 6174 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 1993 | 212 | 0.020 |
Why?
|
| Platelet Aggregation | 2 | 1992 | 771 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1996 | 1056 | 0.020 |
Why?
|
| Estradiol | 1 | 1999 | 1937 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 1996 | 642 | 0.020 |
Why?
|
| Hindlimb | 1 | 2014 | 513 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 829 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1204 | 0.020 |
Why?
|
| Mitogens | 1 | 1991 | 229 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 3607 | 0.020 |
Why?
|
| Methylation | 1 | 2014 | 1077 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1992 | 777 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1058 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 1992 | 240 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2016 | 1202 | 0.020 |
Why?
|
| Selenium | 1 | 2014 | 417 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9171 | 0.020 |
Why?
|
| Homocysteine | 1 | 2014 | 637 | 0.020 |
Why?
|
| Lung | 1 | 2009 | 9999 | 0.020 |
Why?
|
| Hypertrophy | 1 | 1992 | 560 | 0.020 |
Why?
|
| Liposomes | 1 | 1994 | 784 | 0.020 |
Why?
|
| Bronchi | 1 | 1994 | 846 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 1993 | 411 | 0.020 |
Why?
|
| Papio | 1 | 1992 | 669 | 0.020 |
Why?
|
| Polymers | 1 | 1998 | 1614 | 0.020 |
Why?
|
| Cell Death | 1 | 2015 | 1677 | 0.020 |
Why?
|
| Anilides | 1 | 2013 | 411 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 1993 | 552 | 0.020 |
Why?
|
| Microcirculation | 1 | 1995 | 1272 | 0.020 |
Why?
|
| Neuroglia | 1 | 2015 | 954 | 0.020 |
Why?
|
| Atropine | 2 | 2001 | 244 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 1055 | 0.020 |
Why?
|
| Thrombophlebitis | 1 | 1989 | 289 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4569 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1992 | 2261 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4172 | 0.020 |
Why?
|
| Drosophila | 1 | 2015 | 1494 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 2509 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1974 | 1768 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1454 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 3088 | 0.020 |
Why?
|
| Body Composition | 1 | 1996 | 2426 | 0.020 |
Why?
|
| Forecasting | 1 | 2016 | 2924 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1986 | 69 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 1118 | 0.020 |
Why?
|
| Rabbits | 3 | 1998 | 4770 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 1085 | 0.020 |
Why?
|
| Macrophages | 3 | 2005 | 5758 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1974 | 2604 | 0.020 |
Why?
|
| Lipopolysaccharides | 4 | 1995 | 2202 | 0.020 |
Why?
|
| Alprostadil | 2 | 1982 | 86 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 1993 | 834 | 0.020 |
Why?
|
| Leukocytes | 1 | 2014 | 2024 | 0.020 |
Why?
|
| Rhodopsin | 1 | 1986 | 203 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2252 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 460 | 0.020 |
Why?
|
| Chromogenic Compounds | 1 | 2005 | 30 | 0.020 |
Why?
|
| Avidin | 1 | 2005 | 43 | 0.020 |
Why?
|
| S-Nitrosothiols | 1 | 2005 | 35 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 2005 | 166 | 0.020 |
Why?
|
| Resorcinols | 1 | 2005 | 41 | 0.020 |
Why?
|
| Dihydroergotoxine | 2 | 1984 | 21 | 0.020 |
Why?
|
| Alprenolol | 2 | 1982 | 8 | 0.020 |
Why?
|
| DNA Repair | 1 | 1974 | 2043 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 576 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 490 | 0.020 |
Why?
|
| Biotinylation | 1 | 2005 | 184 | 0.010 |
Why?
|
| Placenta | 1 | 1994 | 1709 | 0.010 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11874 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 16572 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 202 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1995 | 11069 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1533 | 0.010 |
Why?
|
| Inflammation | 1 | 2004 | 10759 | 0.010 |
Why?
|
| Cytokines | 2 | 1996 | 7373 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1983 | 107 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 1496 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2004 | 426 | 0.010 |
Why?
|
| Bone Density | 1 | 1996 | 3548 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 201 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1995 | 2515 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1984 | 2410 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2803 | 0.010 |
Why?
|
| Heme | 1 | 2005 | 313 | 0.010 |
Why?
|
| Erythrocyte Membrane | 2 | 1982 | 439 | 0.010 |
Why?
|
| Coronary Artery Bypass | 2 | 2003 | 2188 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2015 | 4210 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 532 | 0.010 |
Why?
|
| Infant | 2 | 2015 | 36157 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Sympatholytics | 1 | 2001 | 82 | 0.010 |
Why?
|
| Cell Survival | 2 | 2003 | 5780 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 577 | 0.010 |
Why?
|
| Female | 6 | 2015 | 392203 | 0.010 |
Why?
|
| Firefly Luciferin | 1 | 2001 | 7 | 0.010 |
Why?
|
| Digitonin | 1 | 1981 | 26 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 578 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 2001 | 44 | 0.010 |
Why?
|
| Octopamine | 1 | 2001 | 43 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 2001 | 88 | 0.010 |
Why?
|
| Spin Trapping | 1 | 2001 | 4 | 0.010 |
Why?
|
| Glucose | 1 | 2013 | 4345 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 2001 | 72 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1990 | 1323 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2004 | 504 | 0.010 |
Why?
|
| Naphthoquinones | 1 | 2001 | 58 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2001 | 126 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2001 | 2234 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 1992 | 2632 | 0.010 |
Why?
|
| Triglycerides | 1 | 2008 | 2459 | 0.010 |
Why?
|
| Zinc | 1 | 2005 | 687 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 836 | 0.010 |
Why?
|
| Peroxisomes | 1 | 2001 | 68 | 0.010 |
Why?
|
| Digoxin | 1 | 2001 | 246 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1992 | 2569 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 2001 | 120 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 1128 | 0.010 |
Why?
|
| NADP | 1 | 2001 | 227 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2001 | 211 | 0.010 |
Why?
|
| Ouabain | 1 | 2000 | 247 | 0.010 |
Why?
|
| Mental Status Schedule | 1 | 2000 | 315 | 0.010 |
Why?
|
| Propranolol | 1 | 2001 | 490 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8652 | 0.010 |
Why?
|
| Benzoates | 1 | 2001 | 212 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 712 | 0.010 |
Why?
|
| Gene Expression | 1 | 1992 | 7569 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2008 | 6390 | 0.010 |
Why?
|
| Cystatin C | 1 | 2000 | 270 | 0.010 |
Why?
|
| Adipose Tissue | 2 | 2008 | 3310 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 8603 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2000 | 260 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1991 | 154 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 1984 | 925 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2001 | 593 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2063 | 0.010 |
Why?
|
| Centrifugation, Isopycnic | 1 | 1997 | 8 | 0.010 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1997 | 19 | 0.010 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 1997 | 15 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2001 | 575 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 1262 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2000 | 539 | 0.010 |
Why?
|
| Risk Factors | 2 | 2016 | 74128 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1991 | 3882 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1997 | 135 | 0.010 |
Why?
|
| Genotype | 2 | 2001 | 12977 | 0.010 |
Why?
|
| Jejunum | 1 | 1998 | 472 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2001 | 992 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 2495 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2001 | 981 | 0.010 |
Why?
|
| Homozygote | 1 | 2000 | 1776 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3776 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 2481 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29601 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 2607 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 1175 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1992 | 898 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 1998 | 664 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2001 | 1866 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2001 | 1788 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 315 | 0.010 |
Why?
|
| Quality of Life | 2 | 1996 | 13359 | 0.010 |
Why?
|
| Thymidine | 1 | 1974 | 297 | 0.010 |
Why?
|
| Haplotypes | 1 | 2000 | 2713 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 169092 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1698 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2747 | 0.010 |
Why?
|
| Cell Communication | 1 | 2001 | 1654 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 299 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3303 | 0.010 |
Why?
|
| Autoradiography | 1 | 1974 | 728 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1703 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 42193 | 0.010 |
Why?
|
| Obesity | 1 | 2015 | 12934 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1991 | 87 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1997 | 1152 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1993 | 522 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1991 | 98 | 0.010 |
Why?
|
| Motor Activity | 1 | 2001 | 2714 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1998 | 1626 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 5863 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 2410 | 0.010 |
Why?
|
| Colon | 1 | 1998 | 1791 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3842 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 4242 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 1603 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1991 | 1085 | 0.010 |
Why?
|
| Renal Artery | 1 | 1991 | 351 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14649 | 0.010 |
Why?
|
| Immune Sera | 1 | 1990 | 605 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 4226 | 0.010 |
Why?
|
| Alleles | 1 | 2000 | 6861 | 0.010 |
Why?
|
| Antibodies | 1 | 1997 | 2413 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1991 | 618 | 0.010 |
Why?
|
| Thrombin | 1 | 1991 | 592 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 59191 | 0.000 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 1932 | 0.000 |
Why?
|
| Risk | 1 | 2000 | 9603 | 0.000 |
Why?
|
| Odds Ratio | 1 | 2000 | 9644 | 0.000 |
Why?
|
| Electrocardiography | 1 | 2001 | 6346 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 550 | 0.000 |
Why?
|
| Transforming Growth Factor beta | 1 | 1995 | 1962 | 0.000 |
Why?
|
| Child | 1 | 2015 | 80089 | 0.000 |
Why?
|
| Adolescent | 1 | 2015 | 88247 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 6126 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1987 | 430 | 0.000 |
Why?
|
| Bone and Bones | 1 | 1996 | 2565 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 1301 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13248 | 0.000 |
Why?
|
| Lipids | 1 | 1996 | 3332 | 0.000 |
Why?
|
| Adenylate Cyclase Toxin | 1 | 1984 | 25 | 0.000 |
Why?
|
| Middle Aged | 3 | 2000 | 220603 | 0.000 |
Why?
|
| Turkeys | 1 | 1984 | 44 | 0.000 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1984 | 73 | 0.000 |
Why?
|
| Bucladesine | 1 | 1984 | 118 | 0.000 |
Why?
|
| Mesocricetus | 1 | 1984 | 252 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1974 | 2909 | 0.000 |
Why?
|
| Fluorides | 1 | 1984 | 134 | 0.000 |
Why?
|
| Educational Status | 1 | 1991 | 2509 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1991 | 2929 | 0.000 |
Why?
|
| Anura | 1 | 1982 | 80 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2000 | 22153 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 6188 | 0.000 |
Why?
|
| Phentolamine | 1 | 1982 | 102 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1984 | 618 | 0.000 |
Why?
|
| Prazosin | 1 | 1982 | 95 | 0.000 |
Why?
|
| Orthopedics | 1 | 1991 | 898 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4947 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3769 | 0.000 |
Why?
|
| Dihydroalprenolol | 1 | 1981 | 8 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1987 | 2601 | 0.000 |
Why?
|
| Ranidae | 1 | 1981 | 32 | 0.000 |
Why?
|
| Phosphorylases | 1 | 1980 | 17 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1980 | 174 | 0.000 |
Why?
|
| Exercise | 1 | 1996 | 5886 | 0.000 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1980 | 177 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 17878 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1991 | 9310 | 0.000 |
Why?
|
| United States | 1 | 2001 | 72292 | 0.000 |
Why?
|